Nuzenio

Tradingview Trvi

Tradingview Trvi entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 11 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Trevi Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 18:04:23 GMTTrevi Therapeutics, Inc. Stock 12‑Month Price Target Raised to $29.17, Implies 58% Upside - TradingViewTradingView · Fri, 07 Aug 2026 17:20:32 GMTTRVI: Advanced chronic cough trials and strong cash position position the company as market leader - TradingViewTradingView · Thu, 06 Aug 2026 21:59:27 GMTTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:40:31 GMTTrevi Therapeutics, Inc. 2Q 2026: Net loss $17.8M, EPS $(0.11) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTTRVI: Advanced Haduvio trials and strong cash position, but net loss rose and more funding is needed - TradingViewTradingView · Thu, 06 Aug 2026 20:18:44 GMTTrevi Therapeutics Q2 net loss widens on higher R&D costs - TradingViewTradingView · Thu, 06 Aug 2026 20:18:40 GMTTrevi Therapeutics reports Q2 2026 net loss of $17.8M; $318.9M cash and marketable securities - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMT

Timeline

Fri, 07 Aug 2026 18:04:23 GMTTrevi Therapeutics Q2 Earnings Call Highlights - TradingView
Fri, 07 Aug 2026 17:20:32 GMTTrevi Therapeutics, Inc. Stock 12‑Month Price Target Raised to $29.17, Implies 58% Upside - TradingView
Thu, 06 Aug 2026 21:59:27 GMTTRVI: Advanced chronic cough trials and strong cash position position the company as market leader - TradingView
Thu, 06 Aug 2026 21:40:31 GMTTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 20:36:00 GMTTrevi Therapeutics, Inc. 2Q 2026: Net loss $17.8M, EPS $(0.11) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:18:44 GMTTRVI: Advanced Haduvio trials and strong cash position, but net loss rose and more funding is needed - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Trvi.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.